GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 634 filers reported holding GLAXOSMITHKLINE PLC in Q2 2013. The put-call ratio across all filers is 0.68 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $202,000 | -24.6% | 4,667 | -29.1% | 0.09% | -25.6% |
| Q1 2016 | $268,000 | +4.3% | 6,580 | +3.1% | 0.12% | +8.7% |
| Q4 2015 | $257,000 | +4.9% | 6,380 | 0.0% | 0.12% | +6.5% |
| Q3 2015 | $245,000 | +11.4% | 6,380 | +33.8% | 0.11% | -10.7% |
| Q1 2015 | $220,000 | +7.8% | 4,770 | 0.0% | 0.12% | +34.4% |
| Q4 2014 | $204,000 | -6.8% | 4,770 | 0.0% | 0.09% | -2.2% |
| Q3 2014 | $219,000 | -14.1% | 4,770 | 0.0% | 0.09% | -16.4% |
| Q2 2014 | $255,000 | 0.0% | 4,770 | 0.0% | 0.11% | -6.0% |
| Q1 2014 | $255,000 | -76.0% | 4,770 | -76.0% | 0.12% | -78.5% |
| Q4 2013 | $1,061,000 | +74.5% | 19,865 | +63.8% | 0.54% | +85.7% |
| Q3 2013 | $608,000 | -1.3% | 12,125 | -1.6% | 0.29% | -1.0% |
| Q2 2013 | $616,000 | – | 12,325 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |